Measles outbreak investigation in factories in central Thailand during June to August 2019

Main Article Content

Thananan Jivaramonaikul
Sumanee Rattanamakka

Abstract

The WHO aims to eliminate measles which is a vaccine preventable disease caused by a paramyxovirus. The symptoms are including fever, rash, Koplik’s spot, myalgia, cough, rhinorrhea. In June 2019, Office of Disease Prevention and Control 4 Saraburi was notified two outbreaks of fever with rash in two factories in different provinces. This investigation has objectives to confirm diagnosis and outbreak, describe epidemiological characteristics of the outbreak, identify sources of infection and mode of transmission, and recommendation for disease control. 154 patients were identified during June to August 2019. Most of them were Myanmar with unknow vaccine history and did not receive Measles and Rubella vaccine in Thailand before started working. The outbreak occurred after that. The first cases of both factories came from the same state in Myanmar. Both factories produce food products. In production plants are cool rooms with wearing personnel protective equipment including gown, groves, mask, hair clovers, and boots are required. Isolation of the patients, quarantine the contacts, and vaccination were done to control the outbreak. The factory with more vaccination given could control the outbreak faster than another factory. The vaccination should be given in those with unknown history of vaccination before working and during the outbreak especially those who could contact to the patients.

Downloads

Download data is not yet available.

Article Details

How to Cite
Jivaramonaikul, T., & Rattanamakka, S. . (2022). Measles outbreak investigation in factories in central Thailand during June to August 2019. Journal of Medical and Public Health Region 4, 12(2), 12–21. Retrieved from https://he01.tci-thaijo.org/index.php/JMPH4/article/view/257388
Section
Investigation Full Report

References

Moss WJ, Griffin DE. Measles. Lancet. 2012;379(9811):153–64.

ปิยนิตย์ ธรรมาภรณ์พิลาศ, เลิศฤทธิ์ ลีลาธร. แนวทางการเฝ้าระวังควบคุม โรค การตรวจรักษา และส่งตัวอย่าง ตรวจทางห้องปฏิบัติการเพื่อการกำจัด โรคหัดตามโครงการกำจัดโรคหัด ตามพันธะสัญญานานาชาติ พิมพ์ครั้งที่ 3.กรุงเทพมหานคร: อักษรกราฟฟิคแอนด์ดีไซน์; 2559

Bester JC. Measles and measles vaccination: A review [Internet]. JAMA Pediatr; 2016 [cited 2022 Jul 5];170(12):1209–15. Available from: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2555881

World Health Organization. Measles factsheet [Internet]; 2007 [cited 26 Nov 2020]. Available from: http://www.who.int/mediacentre/factsheets/ fs286/en/index.html

WHO. Worldwide measles deaths climb 50% from 2016 to 2019 claiming over 207 500 lives in 2019 [Internet]; 2020 [cited 20 Jul 2020]. Available from: https://www.who.int/news/item/12-11-2020-worldwide-measles-deaths-climb-50-from-2016-to-2019-claiming-over-207-500-lives-in-2019

กรมควบคุมโรค. สรุปรายงานการเฝ้าระวังโรค ประจำ ปี 2562. Annual Epidemiological Surveillance Report 2019. 2019; 81-85. เข้าถึงได้จาก https://apps-doe.moph.go.th/boeeng/download/MIX_AESR_2562.pdf

Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, et al. Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis. 2011;204(SUPPL. 1):514–23.

Wongsanuphat S, Thitichai P, Jaiyong R, Plernprom P, Thintip K, Jitpeera C, et al. Investigation of measles outbreak among Thai and migrant workers in two factories in Nakhon Pathom, Thailand, 2019. Int J Environ Res Public Health. 2020;17(13):1–11.

Demicheli V, Rivetti A, Debalini M, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2012; (2):CD004407.

Lievano F, Galea SA, Thornton M, Wiedmann RT, Manoff SB, Tran TN, et al. Measles, mumps, and rubella virus vaccine (M-M-RTMII): A review of 32 years of clinical and postmarketing experience. Vaccine. 2012 Nov 6;30(48):6918–26.